Fremanezumab for the Treatment of Migraine and Major Depressive Disorder
Update: 2025-05-05
Description
Interview with Richard B. Lipton, MD, author of Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder. Hosted by Cynthia E. Armand, MD.
Related Content:
Comments
In Channel




